184 related articles for article (PubMed ID: 34462561)
1. Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming.
Wang P; Jin JM; Liang XH; Yu MZ; Yang C; Huang F; Wu H; Zhang BB; Fei XY; Wang ZT; Xu R; Shi HL; Wu XJ
Acta Pharmacol Sin; 2022 Jun; 43(6):1581-1593. PubMed ID: 34462561
[TBL] [Abstract][Full Text] [Related]
2. Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse.
Yu M; Pan Q; Li W; Du T; Huang F; Wu H; He Y; Wu X; Shi H
Phytomedicine; 2023 Dec; 121():155045. PubMed ID: 37742526
[TBL] [Abstract][Full Text] [Related]
3. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming.
Jin J; Qiu S; Wang P; Liang X; Huang F; Wu H; Zhang B; Zhang W; Tian X; Xu R; Shi H; Wu X
J Exp Clin Cancer Res; 2019 Aug; 38(1):377. PubMed ID: 31455352
[TBL] [Abstract][Full Text] [Related]
4.
An W; Zhang Y; Lai H; Zhang Y; Zhang H; Zhao G; Liu M; Li Y; Lin X; Cao S
Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35730618
[No Abstract] [Full Text] [Related]
5. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways.
Zhang Q; Wang X; Cao S; Sun Y; He X; Jiang B; Yu Y; Duan J; Qiu F; Kang N
Biomed Pharmacother; 2020 Aug; 128():110245. PubMed ID: 32454290
[TBL] [Abstract][Full Text] [Related]
6. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
[TBL] [Abstract][Full Text] [Related]
7. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
8. Xanthatin inhibits human colon cancer cells progression via mTOR signaling mediated energy metabolism alteration.
Li L; Liu P; Xie Y; Liu Y; Chen Z; Geng Y; Zhang L
Drug Dev Res; 2022 Feb; 83(1):119-130. PubMed ID: 34180556
[TBL] [Abstract][Full Text] [Related]
9. PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway in gastric cancer.
Zhang Y; Wu Y; Su X
Front Biosci (Landmark Ed); 2021 Aug; 26(8):322-334. PubMed ID: 34455762
[No Abstract] [Full Text] [Related]
10. FABP4 Regulates Cell Proliferation, Stemness, Apoptosis, and Glycolysis in Colorectal Cancer via Modulating ROS/ERK/mTOR Pathway.
Gao Y; Wang Y; Wang X; Ma J; Wei M; Li N; Zhao Z
Discov Med; 2023 Jun; 35(176):361-371. PubMed ID: 37272103
[TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics.
Wang L; Chen X; Du Z; Li G; Chen M; Chen X; Liang G; Chen T
J Exp Clin Cancer Res; 2017 Mar; 36(1):47. PubMed ID: 28359291
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc.
Du C; Guan X; Liu Y; Xu Z; Du X; Li B; Wang M; Zheng Z
Cancer Chemother Pharmacol; 2022 Apr; 89(4):451-458. PubMed ID: 35201421
[TBL] [Abstract][Full Text] [Related]
13. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway.
Li Z; Li Y; Jia Y; Ding B; Yu J
Arch Biochem Biophys; 2020 May; 685():108352. PubMed ID: 32240637
[TBL] [Abstract][Full Text] [Related]
14.
Qiu X; Jiang Z; Luo Y; Tian D; Song T; Li Q
Front Biosci (Landmark Ed); 2024 Feb; 29(2):48. PubMed ID: 38420800
[TBL] [Abstract][Full Text] [Related]
15. mTOR-mediated metabolic reprogramming shapes distinct microglia functions in response to lipopolysaccharide and ATP.
Hu Y; Mai W; Chen L; Cao K; Zhang B; Zhang Z; Liu Y; Lou H; Duan S; Gao Z
Glia; 2020 May; 68(5):1031-1045. PubMed ID: 31793691
[TBL] [Abstract][Full Text] [Related]
16. Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: involvement of the Akt-mTOR signaling pathway.
Zhao Z; Han F; Yang S; Wu J; Zhan W
Cancer Lett; 2015 Mar; 358(1):17-26. PubMed ID: 25524555
[TBL] [Abstract][Full Text] [Related]
17. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
18. Mammalian target of rapamycin pathway inhibition enhances the effects of 5-aza-dC on suppressing cell proliferation in human gastric cancer cell lines.
Sun D; Toan X; Zhang Y; Chen Y; Lu R; Wang X; Fang J
Sci China C Life Sci; 2008 Jul; 51(7):640-7. PubMed ID: 18622747
[TBL] [Abstract][Full Text] [Related]
19. Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors.
Christians U; Gottschalk S; Miljus J; Hainz C; Benet LZ; Leibfritz D; Serkova N
Br J Pharmacol; 2004 Oct; 143(3):388-96. PubMed ID: 15339861
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential.
Pelicano H; Zhang W; Liu J; Hammoudi N; Dai J; Xu RH; Pusztai L; Huang P
Breast Cancer Res; 2014 Sep; 16(5):434. PubMed ID: 25209360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
